Heron Therapeutics HRTX
NASDAQ HRTX
$0.35 -0.01 (-2.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Heron Therapeutics (HRTX) Change in Acquisitions & Divestments (2016 - 2017)

Updated

Heron Therapeutics (HRTX) reported Change in Acquisitions & Divestments of -$27.3 million for Q2 2017, compared with -$19.64 million a year earlier.

Analysis

Heron Therapeutics (HRTX) Change in Acquisitions & Divestments (2016 - 2017) Analysis & Trends

Over the twelve months ended Jun 30, 2017, Heron Therapeutics' Change in Acquisitions & Divestments came in at -$70.89 million; for FY2016, it came in at -$61.33 million.

  • Per Business Quant data, the three quarters before Q2 2017 came in at -$25.4 million (Q1 2017), -$5.5 million (Q4 2016) and -$12.7 million (Q3 2016).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Heron Therapeutics 66.45 Mn -123.12 Mn 26.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -27.30 Mn
Mar 31, 2017 -25.40 Mn
Dec 31, 2016 -5.50 Mn
Sep 30, 2016 -12.70 Mn
Jun 30, 2016 -19.64 Mn
Mar 31, 2016 -23.49 Mn
API Access

Heron Therapeutics Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=HRTX&period=max&api_key=YOUR_API_KEY